{'fraction_non_alphanumeric': 0.019538188277087035, 'fraction_numerical': 0.010657193605683837, 'mean_word_length': 5.409090909090909, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
New potential biomarkers for disease activity and fibrosis in systemic sclerosis.

S ystemic sclerosis (SSc) is a slowly progressing chronic inflammatory disease that leads to inflammation and fibrosis of the skin and internal organs [1]. Clinically, systemic sclerosis is a heterogeneous disease of different subsets characterized by the extent of skin fibrosis, presence of distinct circulating autoantibodies, and the involvement of internal organs. It is a rare disease with a prevalence ranging from 50 to 300 cases per million with female gender preference.